Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcial Sebode

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|September 2, 2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitisRichard Taubert, Bastian Engel, Jana Diestelhorst, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitisDonald Malino, Greta Codoni, Theresa Kirchner, et al.
Nature|March 25, 2021
Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Journal of Hepatology|March 21, 2026
Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitisYang Xu, Jan Philipp Weltzsch, Christoph Kilian, et al.
Nature|May 11, 2021
Author Correction: Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Cell|June 4, 2019
The Translational Landscape of the Human HeartSebastiaan van Heesch, Franziska Witte, Valentin Schneider-Lunitz, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2024
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary CholangitisLaurent Lam, Pierre-Antoine Soret, Sara Lemoinne, et al.
Journal of Hepatology|October 5, 2025
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitisYu Jun Wong, Laurent Lam, Pierre-Antoine Soret, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|September 2, 2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitisRichard Taubert, Bastian Engel, Jana Diestelhorst, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitisDonald Malino, Greta Codoni, Theresa Kirchner, et al.
Nature|March 25, 2021
Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Journal of Hepatology|March 21, 2026
Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitisYang Xu, Jan Philipp Weltzsch, Christoph Kilian, et al.
Nature|May 11, 2021
Author Correction: Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Cell|June 4, 2019
The Translational Landscape of the Human HeartSebastiaan van Heesch, Franziska Witte, Valentin Schneider-Lunitz, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2024
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary CholangitisLaurent Lam, Pierre-Antoine Soret, Sara Lemoinne, et al.
Journal of Hepatology|October 5, 2025
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitisYu Jun Wong, Laurent Lam, Pierre-Antoine Soret, et al.
Pageof 10